GWPH - GW Pharma Q1 beat propels shares up 4% after hours May, 06 2019 04:11 PM GW Pharmaceuticals Plc GW Pharmaceuticals (NASDAQ:GWPH) Q1 results (): Revenues: 39.2 (+999%); U.S. Epidiolex sales: 33.5.More news on: GW Pharmaceuticals plc, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...